SHALBYNSE27 May 2019

Shalby Limited has informed the Exchange regarding Investor Presentation

Shalby Limited

Download PDF ↗View SHALBY Stock →

MULTI-SPECIALTY

HOSPITALS -

May 25,2019

The Listing Department

Corporate Service Department

National Stock Exchange of India Ltd

BSE Limited

Mumbai 400 051.

Mumbai 400 001.

Scrip Code : SHALBY

Scrip Code: 540797

Sub: lnvestor Presentation for the Fourth Quarter and year ended 31" March 2019, disclosure

under Regulation 30 of SEBl (Listing Obligations and Disclosure Requirements),

Regulations, 2015 ("the SEBI LODR")

Dear Sir / Madam,

We are submitting herewith lnvestor Presentation on financial & operational performance of

the Company for the Fourth Quarter and year ended 31" March 2019, which is also being made

available on our website.

We request t o take the same on your records and disseminate the same t o the members.

Thanking you,

Yours sincerely,

For Shalby Limited

Jayesh Patel

Company Secretary & Compliance Officer

Encl.: as above

Shalby Limited Regd. Off. : Opp. Karnavati Club, S G Road, Ahrnedabad - 380015 (India) Tel. No. : (079) 40203000 I Fax : (079) 40203109 1 www.shalbv.ore: I info@shalby.org 1 CIN : L85110G12004PLC044667 Regd. No. : 061000596 Vapi - lndore - labalpur - Mohali - Naroda (Ahrnedabad) I<rishna Shalby (Ahrnedabad) Surat - laipur Upcoming Hospitals : Nashilc - Mumbai

Investor Presentation Q4 FY19 & FY19

Important Disclosure

No representation or warranty, express or implied is made as to, and no reliance should be placed on, the fairness, accuracy,

completeness or correctness of such information or opinions contained herein. The information contained in this presentation is

only current as of its date. Certain statements made in this presentation may not be based on historical information or facts and

may be “forward looking statements”, including those relating to the Company’s general business plans and strategy, its future

financial condition and growth prospects, and future developments in its industry and its competitive and regulatory

environment. Actual results may differ materially from these forward-looking statements due to a number of factors, including

future changes or developments in the Company’s business, its competitive environment and political, economic, legal and social

conditions in India. This communication is for general information purpose only, without regard to specific objectives, financial

situations and needs of any particular person. This presentation does not constitute an offer or invitation to purchase or

subscribe for any shares in the Company and neither any part of it shall form the basis of or be relied upon in connection with

any contract or commitment whatsoever. The Company may alter, modify or otherwise change in any manner the content of this

presentation, without obligation to notify any person of such revision or changes. This presentation can not be copied and/or

disseminated in any manner.

…because passion drives perfection…

…and perfection drives

performance

“

Shalby Limited

A proxy for growth in the Indian Healthcare space

Current Scale of Operations

11 Hospitals

2,012* Total Bed Capacity

1,102** Operational beds 887 Census Beds 165 Non Census Beds

55% Operating bed to total bed capacity 47% Bed Occupancy (based on census beds)

31% 12 year CAGR Revenue

36% 12 year CAGR EBITDA

500+ Doctors & 2600+ Support Staff

Double-digit return ratios against industry trend of single-digit

Consistently superior ROCE of mature hospitals

* Maximum number of beds according to structure of the hospital

**The operational bed count of 1,102 considers 50 operational beds at Zynova-

Shalby Hospital, Mumbai, for which no other operational parameters are tracked

Promoter

Dr. Vikram Shah Chairman & Managing Director

Qualifications Academic Qualifications: • MBBS • MS (Orthopaedics)

Professional Qualifications • AO Basic Course

(London)

• F.A.O.A.A (Switzerland) • F.A.I.S.F (Germany)

Achievements • Over two and a half decades of professional work experience across UK, USA and India. Serving as Director, Department of Knee Replacement at Shalby Hospitals since 1993

• Dr. Shah innovated zero ‘0’ Technique in 2011 and was awarded the

Double Helical Award 2017, for the innovation

 Reduction of surgery time: 2.5 hours to 22 minutes  Reduction in patient stay: 15 days to 3 days  Drastic fall in infection rates due to minimum incision

• Invented the OS Needle, which is thick bore reverse cutting needle used in attaching soft tissues to the bone. Before the invention of tissue the Needle, procedures that had a very high failure rate. The needle can be attached with commonly available vicryl thread

surgeons had to use complicated soft

• President of Indian Society of Hip & Knee Surgeons (ISHKS) for the

year 2010-11

• Part of joint international faculty for development of new joints by

Zimmer Inc., USA

• Receiver of several awards and accolades by reputed organizations

Our Journey so far…

Started professional practice with a 6-bed facility

Operationalized First Multispecialty Hospital of the group Shalby SG [Bed Capacity: 201]

Commissioned Shalby Jabalpur [Bed Capacity: 233] Commissioned Shalby Indore [Bed Capacity: 243]

1994

2004

2007

2011

2015

2017

228

674

1150

2012

Revenue growth – 100 times in first 10 years Incorporation of Company

Acquired Shalby Vapi [Bed Capacity: 146] Acquired Krishna Shalby [Bed Capacity: 220]

Bed capacity grown 10 times in 10 years – to 2012 beds Commissioned: Shalby Jaipur [Bed Capacity: 237] Shalby Naroda [Bed Capacity: 267] Shalby Surat [Bed Capacity: 243] Shalby Mohali [Bed Capacity: 145]*

*Operationalized in Q1 FY 19

Reach and Presence - Hospitals

Network of Hospitals in India with bed capacity

Mohali – 145 beds

Indore – 243 beds

Ahmedabad SG – 201 beds Krishna – 220 beds Vijay – 27 beds Naroda – 267 beds

Vapi – 146 beds

Jabalpur – 233 beds

Jaipur – 237 beds

Mumbai – 50 beds (Ghatkopar)

Surat – 243 beds

Hospital (operational)

Mumbai – 175 beds (Santacruz) Mumbai – Additional 100 beds (Ghatkopar)

Nashik – 113 beds

Hospital (upcoming)

Has a total bed capacity of 2,012 beds across 11 multi-specialty hospitals

Reach and Presence - OPD

Network of Outpatient Clinics in India

International Footprint

Presence in Africa

Sudan (1)

Addis Ababa (1)

Eldoret

Kisumu Rwanda (1)

Nairobi (1)

Nairobi (1) Dar es Salaam (2)

Kenya

Tanzania

Ethiopia

Sudan

Rwanda

Outpatient clinics

OPD Clinics

Has a network of 40 patient outreach centres in India

International footprint consists of 6 outpatient clinics in Africa

Expansion Plans in Progress

Investment Plans for Upcoming facilities

Nashik

•Bed Capacity 113 •Capex – Rs 25 Crore

Mumbai [Santa Cruz]

•Bed Capacity 175 •Capex – Rs 150 Crore

Mumbai [Ghatkopar]

•Current bed capacity 50. •Addition 100 beds •Capex – Nil

Total capex planned – Rs. 175 Crore for addition of 388 beds

Our Unique Business Model is the key to our outperformance

Our Business Model – features Optimising Capex and Opex

• Lowest Capex and Opex per bed due

to optimal use of real-estate

• Equipment planning and utilities

planning

• In-house planning teams • Focus on surgeries with higher ARPOB, better margins and return ratios

• Centralised procurement • Gradual ramp-up of bed capacity • Fully owned or O&M on revenue sharing (no fixed rentals, no security deposit or MG)

Optimize capex planning with Inhouse projects team

Cost per bed ~ Rs. 3.5 millions

Operational Efficiency due to better capex planning

EBITDA upwards of 20% which is higher than industry average

Utilities planning to optimize capex

Better utilization of space [and expensive real estate]

Low consumable cost

Leveraging economies of scale through centralized procurement

Typical concept of 200 (±20%) bed capacity set-up

Facilities 10-15 kms away

Local and Natural Footfalls from 4- 5 kms radius helps to fill up ~50% beds

Balance ~50% – patients come in the name of doctors reducing thereby dependency on star doctors thus controlling doctor payout %

Our Business Models…

Fully Owned

Efficiency is paramount

Hospital Management Contracts

Operate and Manage [Revenue Sharing]

No fixed rental

Unique revenue sharing model

No security deposit

No minimum guarantee

Role of OPDs for expansion

Patients visit our clinics across India and abroad

Simultaneously hire local doctors and train them at Ahmedabad who conduct OPDs in and around that city

We analyze patient trends and accordingly decide where to expand

So we can start the facility with low branding budget but high brand recall

Punjab

Rajasthan

Gujarat

Ahmedabad

Madhya Pradesh

Maharashtra

Set-up outpatient clinics where we have a strong brand recall

Operating such Outpatient clinics for 15 years now

Case for Expansion

The Opportunity Set

Population and Population Growth Rate of India (Historical and Expected)

CAGR (2014-2020)

100%=

1.27 billion 1.29 billion

1.32 billion

1.35 billion

Spilt of Indian Healthcare Industry by Segments

Total market size (2016): INR 9.2 trillion

9% 4%

13%

68%

0.9%

2.6%

1.6%

0.7%

-0.04%

54+ years

100%

35-54 years

80%

20-34 years

60%

0-19 years

40%

20%

2014(E)

2016(E)

2018(E)

2020(E)

Healthcare Delivery-Hospitals

Diagnostics

Pharma

Health Insurance

Medical Devices

Source: National Commission Population Frost & Sullivan analysis.

The Opportunity Size

Spilt of Public and Private Hospitals in India

Indian Healthcare Delivery Industry size (2015-2020)

(INR in Trillion)

30%

70%

11.7

8.5

7.3

6.2

5.4

Public Hospitals

Private Hospitals

Private Corporate Hospitals account to less than 10% of the total Private Hospitals

2015

2016(E)

2017(E)

2018(E)

2019(E)

2020(E)

Source: Frost & Sullivan analysis.

Recent transformation

• Private sector investment has been increasing due to change in mind-set and better returns on

investment

• Healthcare businesses can also be profitable as long the costs are affordable • The advent of information technology has given a fillip to the healthcare business making it both

controllable and scalable

• Rising aspirational middle-class today is not averse to paying for quality healthcare services • Impact of health insurance, government schemes and emergence of medical tourism - key drivers

of positive change

• Healthcare today in India is evolving to be a larger consumer

story than ever before

Case study - the Cardiac growth story in India

2014 ~ 2,00,000 surgeries and 8,00,000 angioplasties

2004 ~ 50,000 surgeries

1994 ~5000 surgeries

1984 ~500 surgeries

Facilities 10-15 kms away

CAGR – 29% in 30 years. Currently growing @ 2-3%

Wide procedure penetration – to Tier 2 and 3 cities

Source: Industry reports

Knee Replacement - the big opportunity

2017 ~1,75,000 surgeries

2010 ~54,000 surgeries

2000 ~6000 surgeries

1994 ~300 surgeries

Last year, In United States ~0.8 mn knee replacements in a population of ~300 mn

India has a similar affording population. Hence, direct potential to grow to 8 lacs Knee replacements

Hence huge potential for growth based on incidence rates

Asian population 15 times more prone to Arthritis of knee than their western counter parts

Source: Industry reports

Surgery Count CAGR @32% in 23 years

Growth Drivers for Shalby

Pioneer in Joint Replacements in the country, best positioned to capitalize on it

Opportunities within Homecare

Huge scope for organic growth and operating leverage

Continue to gain traction within Oncology and Neurology

Cardiac Sciences, and Critical Care

Increasing focus on quaternary treatments like organ transplants such as Liver, Heart, Lungs and Kidney

Conducive Government Policies Despite Challenges

Swastha Bharat, Smriddha Bharat. Demographic dividend realization impossible without proper healthcare Rashtriya Samaj Beema Yojana: 100 mln families will get Rs 500,000 per year for their families to cover secondary and tertiary hospital expenses

State Policies include capital subsidy on purchase of medical equipment, capital investment subsidy on construction of tertiary-care hospitals and interest subvention, along with several other benefit

100% depreciation on capex incurred, MAT credit can be availed for 15 years, all Wide procedure penetration – healthcare education and training services exempted from GST to Tier 2 and 3 cities

Track record

Best in class economic returns

4706

250%

1200

1000

149%

55%

38%

3,923

3,305

2,927

29% 26% 36%

2,776

2,617 14% 6% 5% 13% 19% 20%

2,298

1,685

1,332

1,030

745

482

194

150%

50%

-50%

-150%

-250%

FY07 FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19

Revenue (in Mn)

Growth (%)

26%

25% 25%

21%

660 687

24%

778

20%

579

482

439

40%

925 907

30%

24%

19%

20%

10%

-10%

-20%

800

16%

20%

600

11%

14% 14%

400

200

262

77 107 142

FY07FY08FY09FY10FY11FY12FY13FY14FY15FY16FY17FY18FY19

EBITDA (in Mn)

Margin (%)

5020

4020

3020

2020

1020

Revenue CAGR growth 31% in last 12 years

EBITDA CAGR growth 36% in last 12 years

Best in class economic returns

RoCE%

RoE%

88% 66%

51%

36%

22%

20%

26%

15%

8,553 8408

17%

28% 31%

26% 20%

15%

13% 11%

14% 13% 10% 7%

5,488

4,153

7,615 7798

2,544

1,817

1,207

852

239 181 163 314

203 259 345 481

2,109

1,814

1,487

2,508

844 1,096

FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19

Capital Employed (Rs in Mn)

RoCE(%)

Net Worth (Rs in Mn)

RoE(%)

Performance Q4FY19

Key Achievements of the Quarter

Cancer Surgeon team at Shalby successfully performed Esophageal Cancer (Cancer of the Food Pipe) through Keyhole Surgery avoiding the need for Open Chest Surgery

Gall Bladder Cancer in an 84 year old patient cured at Shalby through surgery and treatment

Blockage in Vein supplying blood to Liver, removed in a rare surgery at Shalby Hospitals

Wide procedure penetration – to Tier 2 and 3 cities

IP and OP Count (Quarterly Trend)

Surgeries Count (Quarterly Trend)

Arthroplasty Vs Others

47%

50%

51%

48%

49%

53%

50%

54%

58%

55%

56%

55%

53%

50%

49%

52%

51%

47%

50%

46%

42%

45%

44%

45%

Q1FY17

Q2FY17

Q3FY17

Q4FY17

Q1FY18

Q2FY18

Q3FY18

Q4FY18

Q1FY19

Q2FY19

Q3FY19

Q4FY19

Arthroplasty

Others

Performance Synopsis Q4 FY19

Particulars

Quarter Ended 31-03-19

% of Revenue

Quarter Ended 31-03-18

% of Revenue

Growth

Total Revenue (INR in million)

Total EBITDA (INR in million)

1153.9

169.8

14.7%

1110.4

172.1

15.5%

Bed Capacity (Nos.)

Operational Beds (Nos.)

Average Length of Stay

Occupancy (Beds)

In-Patient Count (Nos.)

Out patient Count (Nos.)

Surgeries Count

ARPOB ( In Rs.)

2012

1102

2.45

417

15316*

77140

4893

30760

2012

1102

3.6

396

9998

64189

4802

30625

(1%)

N.A

53%

20%

0.4%

* Increase in IP Count is witnessed due to drastic increase of day care procedures like Radiation therapy, Dialysis etc in Units having < 2 years of Maturity Profile

Note: The operational bed count of 1,102 considers 50 operational beds at Zynova-Shalby Hospital, Mumbai, for which no other operational parameters are tracked

Financial Highlights Q4FY19 Standalone

Particulars

Revenue from Operations Other Income Total Income Expenses Materials & Consumables Fees to Doctors and Consultants Other Operative Expenses Employee Costs Administrative Expenses Advt. & Promotion Total Operational Expenses EBITDA Finance Cost Depreciation & Amortization Expense Profit before tax (PBT) Tax Expense Profit after tax (PAT)

Quarter Ended 31-03-19

% of Revenue

Quarter Ended 31-03-18

% of Revenue

Growth

(INR in million)

1126.8 27.1 1153.9

316.5 328.7 35.3 217.1 69.5 16.9 984.1 169.8 22.1 78.8 68.9 35.0 33.9

27.4% 28.5% 3.1% 18.8% 6.0% 1.5% 85.3% 14.7%

2.9%

1083.7 26.7 1110.4

264.4 300.1 78.3 139.1 122.8 33.5 938.3 172.1 (3.1) 64.1 111.1 (71.8) 182.9

4.0% 1.6% 3.9%

(1.3%)

(38.0%)

23.8% 27.0% 7.1% 12.5% 11.1% 3.0% 84.5% 15.5%

16.5%

(81.5%)

Company is falling under MAT for FY19 as well as FY18 and taxed @ 21.54%

Financial Parameters Q4 FY19

1153.9

172.1

182.86

1110.4

169.8

Q4 FY19

Q4 FY18

Q4 FY19

Q4 FY18

Q4 FY19

Q4 FY18

Total Revenue ( In Rs. Mn.)

EBITDA ( In Rs. Mn.)

PAT ( In Rs. Mn.)

33.9

ARPOB and ALOS (Quarterly)

30760

2.4

30900

30700

30500

30300

30100

29900

29700

29500

29300

3.6

30625

3.5

2.5

1.5

Q4 FY19

Q4 FY18

ARPOB ( In Rs / day)

ALOS

* Decrease in ALOS is witnessed due to drastic increase of day care procedures like Radiation therapy, Dialysis etc in Units having < 2 years of Maturity Profile

Revenue Mix Q4FY19

Specialty Mix

11%

12%

43%

Payer Profile

22%

51%

Arthroplasty

Cardiac Science

Other Ortho

Nephrology

Critical Care & General Medicine

Oncology

Neurology

Others

Self Pay

Corporate Government

TPA

Corporate Private

Surgery Count and Cost Structure Q4FY19

21%

11%

Arthroplasty

General Surgery

Gynecology & IVF

Oncology

2% 6%

19%

29%

27%

Q4 FY19

Advertising & Promotion

Administrative Expenses

45%

Orthopaedic

Nephrology

Cosmetic & Plastic Surgery

Employee Cost

Other Operative Expenses

Others

Fees to Doctors and Consultants

Materials & Consumables

Bed Count Split(Quarterly)

2,012

1,102

396

417

Q4 FY18

Q4 FY19

Bed Capacity

Operational

Occupied

Maturity Profile – Q4FY19

Maturity Profile

Avg. Occupied Beds

Census Beds

Non-Census Beds

Operational Beds

Non- Operational Beds

Total Bed Capacity

4 years + (SG; Vijay; Krishna; Vapi)

2-4 years (Jabalpur, Indore)

< 2 years (Jaipur; Naroda; Surat; Mohali)

159

325

382

212

594

124

309

361

115

476

134

253

309

583

892

Total

417

887

165

1,102*

910

2,012

Note: The operational bed count of 1,102 considers 50 operational beds at Zynova-Shalby Hospital, Mumbai, for which no other operational parameters

are tracked

Maturity Profile – Q4 FY19 vs Q4 FY18 – Operational Parameters

Q4 FY 19

Q4 FY 18

Maturity Profile

IP Count

OP Count

Surgery Count

Maturity Profile

IP Count

OP Count

Surgery Count

4 years + (SG; Vijay; Krishna; Vapi)

4005

29507

2807

4 years + (SG; Vijay; Krishna; Vapi)

4294

30140

2963

2-4 years (Jabalpur, Indore)

3085

22736

937

2-4 years (Jabalpur, Indore)

3303

20575

1039

< 2 years (Jaipur; Naroda; Surat; Mohali)

8226

24897

1,149

< 2 years (Jaipur; Naroda; Surat; Mohali)

2401

13474

800

Total

15316

77140

4,893

Total

9998

64189

4802

Maturity Profile – Q4FY19 – with Revenue mix

Maturity Profile

% of Total Revenue

Arthroplasty

Non Arthroplasty

ARPOB(Rs)

ALOS(Days)

EBITDA %

4 years + (SG; Vijay; Krishna; Vapi)

2-4 years (Jabalpur, Indore)

< 2 years (Jaipur; Naroda; Surat; Mohali)

51%

30%

21%

40966

3.57

27%

20%

16%

20460

3.63

3.8%

29%

20%

27171

1.46

1.3%

Total

100%

43%

57%

30760

2.45

14.7%

Track record (Yearly Trend)

IP and OP Count (Yearly Trend)

OP Count

296197

222,970

125,981 128,821

152,921

166,519

110,919

7,632 19,295

33,285 43,409 55,143

FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19

Surgeries Count (Yearly Trend)

Surgeries Count: Arthroplasty vs Others

11148

9,059

6,361

5,586

6,280

7,399

3,827

6,019

6,856

7,330

8,006

7,816

8,495

8,760

1,900

154 2,596

371

3,576

2,628

2,014

4,442

5,166

FY08

FY09

FY10

FY11

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

Arthroplasty

Others

Surgeries Count (Yearly Trend)

Arthroplasty Vs Others

97%

94%

91%

31%

34%

39%

45%

46%

44%

49%

52%

56%

69%

66%

61%

55%

54%

56%

51%

48%

44%

FY08

FY09

FY10

FY11

FY12

FY13

FY14

FY15

FY16

FY17

FY18

FY19

Arthroplasty

Others

Performance Synopsis FY19

Particulars

Year Ended 31-03-19

% of Revenue

Total Revenue (INR in million)

Total EBITDA (INR in million)

4708.5

908.7

19.3%

Year Ended 31-03-18

3942.35

930.67

Bed Capacity (Nos.)

Operational Beds (Nos.)

Average Length of Stay

Occupancy (Beds)

In-Patient Count (Nos.)

Out patient Count (Nos.)

Surgeries Count

ARPOB ( In Rs.)

2012

1102

2.7

413

55985 *

296,197

19908

31235

2012

1102

3.7

335

32967

222,970

17,554

31564

% of Revenue

Growth

23.6%

19.4%

(2.4%)

N.A

23.3%

69.8%

32.8%

13.4%

(1.0%)

* Increase in IP Count is witnessed due to drastic increase of day care procedures like Radiation therapy, Dialysis etc in Units having < 2 years of Maturity Profile

Note: The operational bed count of 1102 considers 50 operational beds at Zynova-Shalby Hospital, Mumbai, for which no other operational parameters are tracked

Financial Highlights FY19 Standalone

Particulars

Year ended 31-03-19

% of Revenue

Year ended 31-03-18

% of Revenue

Growth

(INR in million)

4611.1 97.5 4708.5

1215.4 1243.1 155.6 851.4 265.6 68.8 3799.8 908.7 71.4 330.0 507.3 186.2 321.0

3855.2 87.1 3942.4

947.7 898.1 326.7 447.9 319.6 71.7 3011.7 930.7 121.3 224.3 585.01 144.9 440.2

19.6% 11.9% 19.4%

(2.4%)

(13.3%)

24.0% 22.8% 8.3% 11.4% 8.1% 1.8% 76.4% 23.6%

11.2%

(27.1%)

25.8% 26.4% 3.3% 18.1% 5.6% 1.5% 80.7% 19.3%

6.8%

Company is falling under MAT for FY19 as well as FY18 and taxed @ 21.54%

Financial Parameters FY19

4708.5

3942.4

930.7

440.2

908.7

321

FY19 Total Revenue ( In Rs. Mn.)

FY18

FY19

FY18

Operational Ebitda ( In Rs. Mn.)

FY19

FY18

PAT ( In Rs. Mn.)

ARPOB and ALOS (Yearly)

32000

31500

31000

30500

30000

29500

3.7 31564

31235

2.7

FY19

FY18

ARPOB ( In Rs / day)

ALOS

3.5

2.5

1.5

* Decrease in ALOS is witnessed due to drastic increase of day care procedures like Radiation therapy, Dialysis etc in Units having < 2 years of Maturity Profile

Revenue Mix FY19

Specialty Mix

10%

11%

45%

Payer Profile

15%

20%

60%

Arthroplasty Cardiac Science Other Ortho Nephrology

Critical Care & General Medicine Oncology Neurology Others

Self Pay

Corporate Government

TPA

Corporate Private

Surgery Count and Cost Structure FY19

Cost Structure

44%

20%

13%

Arthroplasty

General Surgery

Orthopaedic

Nephrology

2% 6%

18%

26%

FY19

Gynecology & IVF

Cosmetic & Plastic Surgery

Materials & Consumables

Fees to Doctors and Consultants

Oncology

Others

Other Operative Expenses

Employee Cost

Administrative Expenses

Advertising & Promotion

Bed Count Split(Yearly)

2,012

1,102

335

FY18

413

FY19

Bed Capacity

Operational

Occupied

Maturity Profile – FY19 – with Revenue mix

Maturity Profile

% of Total Revenue

Arthroplasty

Non Arthroplasty

ARPOB(Rs)

ALOS(Days)

EBITDA %

4 years + (SG; Vijay; Krishna; Vapi)

2-4 years (Jabalpur, Indore)

< 2 years (Jaipur; Naroda; Surat; Mohali)

51%

31%

20%

42107

3.32

30%

22%

18%

20735

3.64

9.0%

28%

10%

18%

29127

1.76

7.3%

Total

100%

45%

55%

31235

2.69

19.3%

Maturity Profile – Operational Parameters

FY 19

FY 18

Maturity Profile

IP Count

OP Count

Surgery Count

Maturity Profile

IP Count

OP Count

Surgery Count

4 years + (SG; Vijay; Krishna; Vapi)

17019

115093

10792

4 years + (SG; Vijay; Krishna; Vapi)

15,989

110710

12,026

2-4 years (Jabalpur, Indore)

13640

91021

4193

2-4 years (Jabalpur, Indore)

11,725

74,357

3,317

< 2 years (Jaipur; Naroda; Surat; Mohali)

25326

90083

4923

< 2 years (Jaipur; Naroda; Surat; Mohali)

5,253

37,903

2,211

Total

55985

296197

19908

Total

32967

222970

17554

Maturity Profile – FY19 – with Revenue mix

Maturity Profile

% of Total Revenue

Arthroplasty

Non Arthroplasty

ARPOB(Rs)

ALOS(Days)

EBITDA %

4 years + (SG; Vijay; Krishna; Vapi)

2-4 years (Jabalpur, Indore)

< 2 years (Jaipur; Naroda; Surat; Mohali)

51%

30%

21%

42107

3.32

30%

22%

18%

20735

3.64

9.0%

28%

10%

18%

29127

1.76

7.3%

Total

100%

44%

56%

31235

2.69

19.3%

Shareholding Pattern

0.31%

0.55%

0.91%

0.94%

4.85%

5.54%

7.00%

Shareholding as on 31st March 2019

0.03% 0.30%

0.12%

0.05%

79.41%

Promoter Individuals

Resident Individuals

Foreign Portfolio - Corp

Bodies Corporates

Employee Trusts

Alternative Investment Fund

H U F

Non Resident Indians

Mutual Funds

Non Resident Indian Non Repatriable Banks

Others

Dividend for FY 2018-19

We take pleasure to inform that Company has recommended dividend of 5% .

Our Strengths and Differentiators

Experienced promoters with hands-on involvement

Strong brand, global leadership in Joint Replacement

Optimized Business Model now being replicated

Increasing focus on Quaternary treatments such as Oncology and Organ transplants

Even after the IPO promoter holding is ~80%

Unleveraged Balance Sheet

Strong emphasis on governance and compliance

Leadership and succession plan in place

Detailed Information

For more detailed information please click on the link below: • Q4FY19 result • Q3FY19 result • Q2FY19 result • Q1FY19 result • Monitoring Agency Report for IPO proceeds • FY19 result

Thank you

SHALBY LIMITED

Regd Off: Opp. Karnavati Club, S.G. Road, Ahmedabad – 380015, Gujarat, India. Phone: 079 4020 3000 Fax: +91 79 4020 3120 | Website: www.shalby.org | CIN: L85110GJ2004PLC044667

Script code: BSE: 540797 | NSE: SHALBY

← All Transcripts SHALBY Stock Page →

Shalby Limited has informed the Exchange regarding Investor Presentation

Market Movers